Stay updated with breaking news from Garyl crocker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of NASDAQ MACK opened at $5.49 on Friday. The business has a fifty day simple moving average of $5.82 and […] ....
StockNews.com started coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report released on Saturday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. NASDAQ:MACK opened at $5.25 on Friday. The company has a market capitalization of $70.40 million, a price-to-earnings ratio of -37.50 and a beta of 1.68. Merrimack […] ....
StockNews.com started coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report released on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Merrimack Pharmaceuticals stock opened at $5.20 on Friday. Merrimack Pharmaceuticals has a fifty-two week low of $3.66 and a fifty-two week high of $7.41. The stock […] ....
StockNews.com began coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report issued on Wednesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK opened at $5.58 on Wednesday. The stock’s 50-day moving average is $6.24 and its two-hundred day moving average is $5.15. The stock has […] ....
StockNews.com assumed coverage on shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) in a report issued on Monday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Shares of MACK stock opened at $6.24 on Monday. Merrimack Pharmaceuticals has a 12 month low of $3.66 and a 12 month high of $7.97. The […] ....